Seelos Therapeutics Inc SEEL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 9:33 AM EDT
4.98quote price arrow down-0.12 (-2.35%)
Volume
58,809
52 week range
0.45 - 6.16

...

Loading . . .
  • Open5.01
  • Day High5.05
  • Day Low4.96
  • Prev Close5.10
  • 52 Week High6.16
  • 52 Week High Date04/07/21
  • 52 Week Low0.45
  • 52 Week Low Date04/21/20

Key Stats

  • Market Cap389.83M
  • Shares Out78.28M
  • 10 Day Average Volume4.89M
  • Dividend-
  • Dividend Yield-
  • Beta2.93
  • YTD % Change222.78

KEY STATS

  • Open5.01
  • Day High5.05
  • Day Low4.96
  • Prev Close5.10
  • 52 Week High6.16
  • 52 Week High Date04/07/21
  • 52 Week Low0.45
  • 52 Week Low Date04/21/20
  • Market Cap389.83M
  • Shares Out78.28M
  • 10 Day Average Volume4.89M
  • Dividend-
  • Dividend Yield-
  • Beta2.93
  • YTD % Change222.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-11.50
  • Fwd P/E (NTM)-12.87
  • EBITDA (MRQ)-18.759M
  • ROE (MRQ)-1,489.36%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)79.21%
  • Net Margin (MRQ)-5,984.27%
  • Debt To Equity (MRQ)378.07%

EVENTS

  • Earnings Date05/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Seelos Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Seelos Therapeutics, Inc., formerly Apricus Biosciences, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing technologies and therapeutics for the treatment of central nervous system, respiratory disorders. The Company is engaged in developing its lead programs SLS-002 and SLS-006. The Company is also engaged in developing several preclinical programs, which include SLS-008, SLS-007 SLS-010 and SLS-012. SLS-002 is intranasal racemic...
Raj Mehra
Chairman
Address
300 Park Avenue
New York, NY
10017
United States

Top Peers

SYMBOLLASTCHG%CHG
CRMD
CorMedix Inc
7.40-0.11-1.46%
TNXP
Tonix Pharmaceuticals Holding Corp
0.9311-0.0689-6.89%
ETON
Eton Pharmaceuticals Inc
7.76+0.01+0.06%
INFI
Infinity Pharmaceuticals Inc
2.78UNCHUNCH
SCPH
scPharmaceuticals Inc
6.32+0.06+1.04%